Dinutuxumab Beta Plus Conventional Chemotherapy for Relapsed/Refractory High-Risk Neuroblastoma: A Single Centre Experience

被引：0
|
作者：
Olgun, N. [1 ]
Cecen, R. E. [1 ]
Ince, D. [1 ]
Onal, A. [1 ]
Baysal, B. [2 ]
Akyol, S. [1 ]
Ozdogan, O. [3 ]
Guleryuz, H. [4 ]
Aktas, S. [1 ]
Ozer, E. [5 ]
机构：
[1] Dokuz Eylul Univ, Inst Oncol, Izmir, Turkey
[2] Marmara Univ, Educ & Res Hosp, Pediat Hematol & Oncol, Istanbul, Turkey
[3] Dokuz Eylul Univ, Nucl Med, Izmir, Turkey
[4] Dokuz Eylul Univ, Radiodiagnost, Izmir, Turkey
[5] Dokuz Eylul Univ, Pathol, Izmir, Turkey
来源：
PEDIATRIC BLOOD & CANCER | 2021年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PV0129
引用
收藏
页码：S215 / S215
页数：1
相关论文
共 50 条
  • [31] Outcome in patients with refractory high-risk neuroblastoma.
    Siddiqui, Amir Bari
    Oppong, Akosua
    Yuan, Cindy
    Gao, Guimin
    Bagatell, Rochelle
    Berg, Katherine
    Sokol, Elizabeth
    MacQuarrie, Kyle
    Pinto, Navin R.
    Gollapudi, Anurekha
    Mody, Rajen
    Wolfe, Ian
    Shusterman, Suzanne
    Foster, Jennifer
    Smith, Valeria
    Cohn, Susan Lerner
    Desai, Ami Vijay
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [32] Nivolumab Plus ICE As First Salvage Therapy in High-Risk Relapsed/Refractory Hodgkin Lymphoma
    Mei, Matthew
    Palmer, Joycelynne
    Tsai, Ni-Chun
    Lee, Hun Ju
    Isufi, Iris
    Popplewell, Leslie L.
    Smith, Lynne
    Peters, Lacolle
    Rodriguez, Lara
    Godfrey, James
    Baird, John H.
    Song, Joo Y.
    Rosen, Steven T.
    Kwak, Larry W.
    Forman, Stephen J.
    Herrera, Alex F.
    BLOOD, 2022, 140
  • [33] High-dose chemotherapy and autologous stem cell transplantation in childhood relapsed or refractory Hogkin disease -: a single-centre experience
    Caldas, G
    Mendonça, T
    Ferreira, I
    Lacerda, A
    Neto, A
    Teixeira, A
    Weira, E
    Pereira, F
    Ribeiro, MJ
    Chagas, M
    Miranda, N
    Guimaraes, A
    Abecasis, M
    BONE MARROW TRANSPLANTATION, 2006, 37 : S210 - S211
  • [34] Use of Dinutuximab/Dinutuximab Beta in Patients with High Risk and Relapsed Neuroblastoma. Experience in Argentina
    Nana, M.
    Cores, M.
    Urbieta, M.
    Garcia Lombardi, M.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S323 - S324
  • [35] Dinutuximab Beta Maintenance Therapy in Patients with High-Risk Neuroblastoma in First-Line and Refractory/Relapsed Settings-Real-World Data
    Wieczorek, Aleksandra
    Zebrowska, Urszula
    Ussowicz, Marek
    Sokol, Agnieszka
    Stypinska, Marzena
    Dembowska-Baginska, Bozenna
    Pawinska-Wasikowska, Katarzyna
    Balwierz, Walentyna
    Barutello, Giuseppina
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (16)
  • [36] CONVENTIONAL CHEMOTHERAPY OF HIGH-RISK TESTICULAR CANCER
    CHEVREAU, C
    PATHOLOGIE BIOLOGIE, 1994, 42 (10): : 992 - 993
  • [37] Surgical Outcomes in Patients with High Risk Neuroblastoma, the European High Risk Neuroblastoma-1 Trial: A UK Single Centre Experience
    Hotonu, S.
    Lisseter, R.
    Campbell-Hewson, Q.
    Tweddle, D.
    Gabra, H.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S474 - S475
  • [38] High-dose chemotherapy in patients with high-risk Ewing's sarcoma of pelvis. A single-centre experience
    Dolgopolov, I.
    Boyarshinov, V.
    Pimenov, R.
    Subbotina, N.
    Visotchin, I.
    Siegel, S.
    Mentkevich, G.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S226 - S226
  • [39] Therapy With Dinutuximab Beta in Combination With Chemotherapy in Patients With Refractory Relapsed Neuroblastoma. Initial Results
    Wieczorek, A.
    Zaniewska-Tekieli, A.
    Gizycka, A.
    Balwierz, W.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S272 - S272
  • [40] A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome
    Saygin, Caner
    Larkin, Karilyn
    Blachly, James S.
    Orwick, Shelley
    Ngankeu, Apollinaire
    Gregory, Charles T.
    Phelps, Mitch A.
    Mani, Shylaja
    Walker, Alison
    Garzon, Ramiro
    Vasu, Sumithira
    Walsh, Katherine J.
    Bhatnagar, Bhavana
    Klisovic, Rebecca B.
    Grever, Michael R.
    Marcucci, Guido
    Byrd, John C.
    Blum, William
    Mims, Alice S.
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (12) : 1457 - 1465
12345